The Santen Pharmaceutical Co., Ltd. rebuilt its sales analysis system on the MicroStrategy Business Intelligence Platform. Santen Pharmaceutical Co. is dedicated to innovations in eye and healthcare, and devotes its managerial resources to developing ophthalmic and antirheumatic
pharmaceuticals.
After evaluating numerous business intelligence vendors, Santen Pharmaceutical Co., Ltd. chose MicroStrategy for its ability to meet Santen’s current business intelligence needs and provide Web-based functionality across the enterprise. With MicroStrategy software, Santen
Pharmaceutical Co. has an integrated business intelligence platform that can keep up with constantly evolving user requirements. The MicroStrategy system will allow Santen’s sales representatives throughout Japan to focus on their sales activity using only a Web browser.
“MicroStrategy’s software platform is highly scalable, offers superior performance and allows our end users to obtain critical business insight with ease,” said Santen Pharmaceutical’s General Manager for Corporate Services and IS Solution Group. “Santen Pharmaceutical aims
to drive sales activity with its MicroStrategy platform.”
Since its foundation in 1890, Santen Pharmaceutical Co., Ltd. has contributed to the protection and improvement of people’s eyesight and health. Santen’s integrated operations extend from research
and development to production and sales of prescription and over-the-counter pharmaceuticals. Santen specializes in original ophthalmic and anti-rheumatic pharmaceuticals as it works to create superior pharmaceuticals for all types of ophthalmic disorders and offer information that meets
clinical needs. As a result, Santen leads Japan’s market for prescription ophthalmics, which represent nearly 80 percent of Company sales. With marketing and development bases in Japan, the United
States and Europe, backed by first-rate R&D capabilities, Santen aims to increase corporate value to become a world-class company that delivers unique products to patients worldwide.